The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Calcium carbonate nanoparticles as cancer drug delivery system
Abstract
INTRODUCTION: Calcium carbonate (CaCO3) has broad biomedical utilizations owing to its availability, low cost, safety, biocompatibility, pH-sensitivity and slow biodegradability. Recently, there has been widespread interest in their application as drug delivery systems for different groups of drugs. Among them, CaCO3 nanoparticles have exhibited promising potential as drug carriers targeting cancer tissues and cells. The pH-dependent properties, alongside the potential to be functionalized with targeting agents give them the unique property that can be used in targeted delivery systems for anticancer drugs. Also, due to the slow degradation of CaCO3 matrices, these nanoparticles can be used as sustained release systems to retain drugs in cancer tissues for longer times after administration. AREAS COVERED: Development of drug delivery carriers using CaCO3 nanoparticles has been reviewed. The current state of CaCO3 nanoparticles as cancer drug delivery systems with focus on their special properties like pH-sensitivity and biodegradability has also been evaluated. EXPERT OPINION: According to our review, CaCO3 nanoparticles, owing to their special characteristics, will have a potential role in safe and efficient cancer treatment in future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Taking advantage of disorder: amorphous calcium carbonate and its roles in biomineralization
Addadi, L., Raz, S., & Weiner, S. (2003) · Advanced Materials · doi:10.1002/adma.200300381 · Cited by 1,594
Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting
Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841
Cited by
Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics
Gong, F., Yang, N., Wang, X., Zhao, Q., Chen, Q., Liu, Z., & Cheng, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100851 · Cited by 359
Xue, C.-C., Li, M.-H., Zhao, Y., Zhou, J., Hu, Y., Cai, K.-Y., Zhao, Y., Yu, S.-H., & Luo, Z. (2020) · Science Advances · doi:10.1126/sciadv.aax1346 · Cited by 299
Auría-Soro, C., Nesma, T., Juanes-Velasco, P., Landeira-Viñuela, A., Fidalgo-Gomez, H., Acebes-Fernandez, V., Gongora, R., Almendral Parra, M. J., Manzano-Roman, R., & Fuentes, M. (2019) · Nanomaterials · doi:10.3390/nano9101365 · Cited by 289
Dong, Z., Feng, L., Zhu, W., Sun, X., Gao, M., Zhao, H., Chao, Y., & Liu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.025 · Cited by 284
Calcium-based biomaterials for diagnosis, treatment, and theranostics
Qi, C., Lin, J., Fu, L.-H., & Huang, P. (2018) · Chemical Society Reviews · doi:10.1039/c6cs00746e · Cited by 265
Metadata
- Authors
- Maleki Dizaj, S., Barzegar-Jalali, M., Zarrintan, M. H., Adibkia, K., & Lotfipour, F.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2015-05-25
- Volume
- 12
- Issue
- 10
- Pages
- 1649-1660
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W1678646445
- Cited by
- 310
- References
- 3
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcium carbonate nanoparticles as cancer drug delivery system. https://app.cochat.ai/papers/10.1517/17425247.2015.1049530
- The paper
- Maleki Dizaj, S., Barzegar-Jalali, M., Zarrintan, M. H., Adibkia, K., & Lotfipour, F. (2015). Calcium carbonate nanoparticles as cancer drug delivery system. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2015.1049530
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.